SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-17-200127
Filing Date
2017-06-09
Accepted
2017-06-09 16:31:59
Documents
4
Period of Report
2017-06-07
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d406783d8k.htm 8-K 74506
2 EX-3.1 d406783dex31.htm EX-3.1 217761
3 EX-3.2 d406783dex32.htm EX-3.2 234183
4 GRAPHIC g406783g79m35.jpg GRAPHIC 2902
  Complete submission text file 0001193125-17-200127.txt   532242
Mailing Address 225 BINNEY STREET CAMBRIDGE MA 02142
Business Address 225 BINNEY STREET CAMBRIDGE MA 02142 7814642000
BIOGEN INC. (Filer) CIK: 0000875045 (see all company filings)

IRS No.: 330112644 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-19311 | Film No.: 17903324
SIC: 2836 Biological Products, (No Diagnostic Substances)